Search

Your search keyword '"Hosoda F"' showing total 98 results

Search Constraints

Start Over You searched for: Author "Hosoda F" Remove constraint Author: "Hosoda F"
98 results on '"Hosoda F"'

Search Results

2. Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples

3. Sex differences in oncogenic mutational processes

9. Report of the Sixth International Workshop on Human Chromosome 11 Mapping 1998

11. The isolation of CpG islands from human chromosomal regions 11q13 and Xp22 by segregation of partlymelted molecules.

13. Sixth International Workshop on Human Chromosome 11 Mapping, Nice, Paris, 2-5 May, 1998

14. Deletion of the TNFAIP3/A20 gene detected by FICTION analysis in classical Hodgkin lymphoma

15. Pan-cancer analysis of whole genomes

16. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples

17. Genomic and Pathologic Profiling of Very Well-Differentiated Gastric Adenocarcinoma of Intestinal Type: A Study With Emphasis on Diffuse-Type Transformation.

18. Oncogenic structural aberration landscape in gastric cancer genomes.

19. Multiancestry genomic and transcriptomic analysis of gastric cancer.

20. Comprehensive biomarker analysis from phase II study of nivolumab in patients with thymic carcinoma.

21. Pharmacokinetic and pharmacogenomic analysis of low-dose afatinib treatment in elderly patients with EGFR mutation-positive non-small cell lung cancer.

22. DNA Adductome Analysis Identifies N -Nitrosopiperidine Involved in the Etiology of Esophageal Cancer in Cixian, China.

23. Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer.

24. Initial and crucial genetic events in intestinal-type gastric intramucosal neoplasia.

25. Exploration of germline variants responsible for adverse events of crizotinib in anaplastic lymphoma kinase-positive non-small cell lung cancer by target-gene panel sequencing.

26. Integrated genetic and epigenetic analysis of myxofibrosarcoma.

27. Epigenetic landscape influences the liver cancer genome architecture.

28. Highly recurrent H3F3A mutations with additional epigenetic regulator alterations in giant cell tumor of bone.

29. Comprehensive mutation profiling of mucinous gastric carcinoma.

31. Recurrent neomorphic mutations of MTOR in central nervous system and testicular germ cell tumors may be targeted for therapy.

32. Erratum: Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer.

33. Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer.

34. Genomic Sequencing Identifies ELF3 as a Driver of Ampullary Carcinoma.

35. Genomic spectra of biliary tract cancer.

36. Trans-ancestry mutational landscape of hepatocellular carcinoma genomes.

37. Unique mutation portraits and frequent COL2A1 gene alteration in chondrosarcoma.

38. Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma.

39. Signatures of mutational processes in human cancer.

40. Regulatory nexus of synthesis and degradation deciphers cellular Nrf2 expression levels.

41. Mouse model for ROS1-rearranged lung cancer.

42. Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators.

43. High-resolution characterization of a hepatocellular carcinoma genome.

44. Copy number alterations in urothelial carcinomas: their clinicopathological significance and correlation with DNA methylation alterations.

45. Diagnosis and prognostication of ductal adenocarcinomas of the pancreas based on genome-wide DNA methylation profiling by bacterial artificial chromosome array-based methylated CpG island amplification.

46. Genome-wide DNA methylation profiles in renal tumors of various histological subtypes and non-tumorous renal tissues.

47. Genome-wide DNA methylation profiles in urothelial carcinomas and urothelia at the precancerous stage.

48. Genome-wide DNA methylation profiles in liver tissue at the precancerous stage and in hepatocellular carcinoma.

49. Resequencing and copy number analysis of the human tyrosine kinase gene family in poorly differentiated gastric cancer.

50. Krüppel-like factor 12 plays a significant role in poorly differentiated gastric cancer progression.

Catalog

Books, media, physical & digital resources